Marker Therapeutics, Inc. earnings per share and revenue

MRKR earnings per share for the last quarter are -0.41 USD whereas the estimation was -0.22 USD which accounts for -86.36% surprise. Company revenue for the same period amounts to 2.25 M USD despite the estimated figure of 1.22 M USD. Estimated earnings per share for the next quarter are -0.50 USD, and revenue is expected to reach 723.15 k USD. Also watch annual changes over time to get a bigger picture of MRKR earnings per share and revenue dynamics.